SAB Biotherapeutics Completes $85 Million Public Offering

AI Briefing

• – SAB Biotherapeutics completes $85 million public offering
• – Dentons advises SAB Biotherapeutics, Mintz advises underwriters
• – SAB Biotherapeutics is a clinical-stage biopharmaceutical company